Introduction
Clinically, cardiac malignant tumours are extremely rare and primary
cardiac lymphomas (PCL) account for 1-2% of cardiac malignant tumours
therein [1, 2]. Cardiac lymphomas can provoke a wide spectrum of
symptoms, including symptoms of arrhythmia, heart failure, embolism,
dyspnea and fatigue [2-4]. These multiple clinical manifestations of
cardiac lymphomas may depend on the tumor location, pattern of growth,
histologic type, and invasive features, which also lead to misdiagnosis.
Like other malignancies, most cardiac malignant tumours are associated
with a poor outcome, but patients with cardiac lymphoma have a better
prognosis if they are treated timely and appropriately [3].